Literature DB >> 1500203

Induction of circulating group II phospholipase A2 expression in adults with malaria.

P Vadas1, J Keystone, E Stefanski, K Scott, W Pruzanski.   

Abstract

High levels of interleukin 1 and tumor necrosis factor are found in both cases of malaria and cases of septic shock. Since both interleukin 1 and tumor necrosis factor induce expression of the proinflammatory enzyme phospholipase A2 (PLA2), we examined serum PLA2 levels in 14 adults with malaria. Mean serum PLA2 activity was elevated 40-fold above normal (P less than 0.001). Serum PLA2 activity correlated with PLA2 immunoreactivity (r = 0.987; P less than 0.001) by an enzyme-linked immunosorbent assay specific for human group II PLA2, showing that serum PLA2 in cases of malaria is host derived. This article describes the novel finding of elevated PLA2 levels in cases of malaria, further strengthening the notion that mediators of the host response in cases of malaria are similar to those in cases of septic shock.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500203      PMCID: PMC257413          DOI: 10.1128/iai.60.9.3928-3931.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  Phospholipase A2 activation is the pivotal step in the effector pathway of inflammation.

Authors:  P Vadas; W Pruzanski
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

Review 2.  Soluble phospholipase A2 in human pathology: clinical-laboratory interface.

Authors:  W Pruzanski; P Vadas
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

3.  Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum.

Authors:  S Picot; F Peyron; J P Vuillez; G Barbe; K Marsh; P Ambroise-Thomas
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

4.  Demonstration of soluble Plasmodium falciparum antigens reactive with Limulus amoebocyte lysate and polymyxin B.

Authors:  P H Jakobsen; L Baek; S Jepsen
Journal:  Parasite Immunol       Date:  1988-11       Impact factor: 2.280

Review 5.  Tumor necrosis factor alpha: a multifaceted peptide hormone.

Authors:  M G Rosenblum; N J Donato
Journal:  Crit Rev Immunol       Date:  1989       Impact factor: 2.214

6.  IL-8 in septic shock, endotoxemia, and after IL-1 administration.

Authors:  K J Van Zee; L E DeForge; E Fischer; M A Marano; J S Kenney; D G Remick; S F Lowry; L L Moldawer
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

Review 7.  Antiparasitic effects of tumour necrosis factor in vivo and in vitro.

Authors:  J H Playfair; J Taverne
Journal:  Ciba Found Symp       Date:  1987

Review 8.  Malaria--an overview.

Authors:  H M Gilles
Journal:  J Infect       Date:  1989-01       Impact factor: 6.072

9.  Tumor necrosis factor and disease severity in children with falciparum malaria.

Authors:  G E Grau; T E Taylor; M E Molyneux; J J Wirima; P Vassalli; M Hommel; P H Lambert
Journal:  N Engl J Med       Date:  1989-06-15       Impact factor: 91.245

10.  Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo.

Authors:  C A Bate; J Taverne; J H Playfair
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

View more
  5 in total

1.  In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.

Authors:  Carole Guillaume; Christine Payré; Ikram Jemel; Louise Jeammet; Sofiane Bezzine; Gajendra S Naika; James Bollinger; Philippe Grellier; Michael H Gelb; Joseph Schrével; Gérard Lambeau; Christiane Deregnaucourt
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

2.  Antimalarial Activity of Human Group IIA Secreted Phospholipase A2 in Relation to Enzymatic Hydrolysis of Oxidized Lipoproteins.

Authors:  Mélanie Dacheux; Véronique Sinou; Christine Payré; Louise Jeammet; Daniel Parzy; Philippe Grellier; Christiane Deregnaucourt; Gérard Lambeau
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

3.  Sequence specific inhibition of human type II phospholipase A2 enzyme activity by phosphorothioate oligonucleotides.

Authors:  C F Bennett; M Y Chiang; L Wilson-Lingardo; J R Wyatt
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

Review 4.  Human Group IIA Phospholipase A2-Three Decades on from Its Discovery.

Authors:  Kieran F Scott; Timothy J Mann; Shadma Fatima; Mila Sajinovic; Anshuli Razdan; Ryung Rae Kim; Adam Cooper; Aflah Roohullah; Katherine J Bryant; Kasuni K Gamage; David G Harman; Fatemeh Vafaee; Garry G Graham; W Bret Church; Pamela J Russell; Qihan Dong; Paul de Souza
Journal:  Molecules       Date:  2021-11-30       Impact factor: 4.411

5.  Group II phospholipase A(2) in human gingiva with periodontal disease.

Authors:  H Shinohara; T Komatsubara; H Tojo; M Okamoto; S Nishikawa; T Nagata; H Ishida
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.